Name,Category,Begin Date,End Date,Note
Initial Diagnosis Stage I,Milestones,2020-03-01,,
Lumpectomy,Milestones,2020-03-20,,Clear margins obtained
Receptor Testing,Biomarker Assess,2020-03-25,,Triple negative
Adjuvant AC-T Chemo,Line 1 treatment,2020-04-15,2020-09-01,Standard adjuvant regimen
Radiation,Line 1 treatment,2020-09-15,2020-10-25,Whole breast radiation
Year 1 Surveillance Clear,Milestones,2021-03-20,,NED
Year 2 Surveillance Clear,Milestones,2022-03-20,,NED continued
New Cough Develops,Milestones,2023-01-15,,
CT Chest,Biomarker Assess,2023-01-22,,Multiple lung nodules
Lung Biopsy,Biomarker Assess,2023-01-30,,Metastatic breast cancer confirmed
Distant Recurrence,Complications,2023-02-01,,Stage IV disease
PD-L1 Retesting,Biomarker Assess,2023-02-05,,CPS 8 positive
BRCA Testing,Biomarker Assess,2023-02-05,,Negative
Keytruda/Gemcitabine/Carboplatin,Line 2 treatment,2023-02-20,2023-08-15,First line for metastatic
Restaging PR,Biomarker Assess,2023-05-20,,Partial response
Progression on 1L,Complications,2023-08-20,,Liver mets appeared
Trodelvy 2L Metastatic,Line 3 treatment,2023-09-01,2024-03-15,Sacituzumab govitecan
Stable Disease,Biomarker Assess,2023-12-01,,Liver mets stable
CNS Progression,Complications,2024-03-20,,Brain mets found
SRS Brain,Line 3 treatment,2024-04-01,2024-04-05,Stereotactic radiosurgery 3 lesions
